🔴 Firefly Neuroscience is trading 5.56% down today with no clear company-specific catalyst

Firefly Neuroscience is trading at $1.02 (-5.56%), with no clear company-specific catalyst identified for August 24, 2026.

• Recent disclosures include second-quarter results filed August 11 and earlier operational updates, but neither directly explains today’s decline.
• The latest identified press release, dated August 5, reported increased TMS-center brain-scan volumes.
• Broader markets are mixed to lower; the Nasdaq is down 0.65%, offering limited support for a market-wide explanation.